Hip resurfacing: A complex challenge for device regulation

The Lancet

Volumn 380, Issue 9855, 2012, Pages 1720-1722

  Sedrakyan, Art ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METAL ION; POLYETHYLENE;

CLINICAL PRACTICE; HIP ARTHROPLASTY; HIP PROSTHESIS; HIP RESURFACING; HUMAN; IMPLANTATION; NOTE; ORTHOPEDIC SURGERY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE;

EID: 84869084336     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)61270-7     Document Type: Note

References (15)

1. Cohen D. How safe are metal-on-metal hip implants? BMJ 2012; 344: e1410.
2. Meier B. The high cost of failing artificial hips. New York Times, Dec 27, 2011. http://www.nytimes.com/2011/12/28/business/the-high-cost-of- failingartificial-hips.html?pagewanted=all (accessed Sept 14, 2012).
3. Sedrakyan A. Metal-on-metal failures-in science, regulation, and policy. Lancet 2012; 379: 1174-76.
4. MHRA. Medical device alert: all metal-on-metal (MoM) hip replacements MDA/2012/036. June 25, 2012. http://www.mhra.gov.uk/Publications/Safetywarnings/ MedicalDeviceAlerts/CON155761 (accessed July 16, 2012).
5. McMinn DJ, Daniel J, Ziaee H, Pradhan C. Indications and results of hip resurfacing. Int Orthop 2011; 35: 231-37.
6. Food and Drug Administration. Premarket Approval (PMA). http://www.fda.gov/medicaldevices/deviceregulationandguidance/ howtomarketyourdevice/premarketsubmissions/premarketapprovalpma/default.htm (accessed July 16, 2012).
7. Institute of Medicine. Medical devices and the public's health: the FDA 510(k) clearance process at 35 years. July 29, 2011. http://www.iom.edu/Reports/ 2011/Medical-Devices-and-the-Publics-Health-The-FDA-510k-Clearance-Process-at- 35-Years.aspx (accessed July 18, 2012).
8. Smith AJ, Dieppe P, Howard PW, Blom AW, on behalf of the National Joint Registry of England and Wales. Failure rates of metal-on-metal hip resurfacings: analysis of data from the National Joint Registry of England and Wales. Lancet 2012; published online Oct 2. http://dx.doi:10.1016/S0140-6736(12)60989-1.
9. Sedrakyan A, Marinac-Dabic D, Normand SL, Mushlin A, Gross T. A framework for evidence evaluation and methodological issues in implantable device studies. Med Care 2010; 48 (6 suppl): S121-28.
10. McMinn DJ, Snell KI, Daniel J, Treacy RB, Pynsent PB, Riley RD. Mortality and implant revision rates of hip arthroplasty in patients with osteoarthritis: registry based cohort study. BMJ 2012; 344: e3319.
11. Tower SS. Arthroprosthetic cobaltism associated with metal on metal hip implants. BMJ 2012; 344: e430.
12. Smith AJ, Dieppe P, Porter M, Blom AW. Risk of cancer in first seven years after metal-on-metal hip replacement compared with other bearings and general population: linkage study between the National Joint Registry of England and Wales and hospital episode statistics. BMJ 2012; 344: e2383.
13. MäkeläT, Visuri T, Pulkkinen P, et al. Risk of cancer with metal-on-metal hip replacements: population based study. BMJ 2012; 345: e4646.
14. Smith AJ, Dieppe P, Vernon K, Porter M, Blom AW, on behalf of the National Joint Registry of England and Wales. Failure rates of stemmed metal-on-metal hip replacements: analysis of data from the National Joint Registry of England and Wales. Lancet 2012; 379: 1199-204.
15. Graves SE, Rothwell A, Tucker K, Jacobs JJ, Sedrakyan A. A multinational assessment of metal-on-metal bearings in hip replacement. J Bone Joint Surg Am 2011; 93 (suppl 3): 43-47.